Thus, miRNA-24 targets FSCN1 in nasopharyngeal and prostate cancer [95,102], FSCN1 is targeted by miRNA-143 in esophageal [103] and miRNA-326 in lung and gastric cancers [104,105], respectively. Here, FSCN1 is linked to prostate cancer.